Pfizer in 2019 sold $20 billion of drugs in the U.S. Its federal tax bill? Zero. That revelation was part of a Senate Finance ...

AscellaHealth has introduced its latest Specialty & Rare Pipeline Digest™, a quarterly publication designed to provide ...

The prime minister has begun his sixth day on the campaign trail condemning US tariffs on imported goods while visiting a ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

Calley Means joins Dasha Burns at a Politico health care summit to discuss HHS Secretary Robert F. Kennedy Jr.'s MAHA agenda. In this portion, he calls out food industry lobbyists for influencing the ...

Major pharmaceutical companies reap most of their profits in the U.S. but shift their tax burdens to low-tax havens such as ...

In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.

Siemens’ role in providing advanced technology and expertise in industrial applications is poised to have a long-lasting ...

On Thursday morning, the full U.S. Senate Judiciary Committee will convene an executive business meeting to consider several ...

President Donald Trump is expected to announce sweeping tariffs on “all countries" affecting many industries, the likes of ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

CEO of Vitalograph, which is based in Ennis and makes medical devices, Frank Keane, fears the level of “uncertainty” could reduce consumer spending, causing businesses to fail. The CEO of the ...